跳至主要内容
临床试验/NCT00213785
NCT00213785已完成不适用

A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2001年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
1

研究概览

简要总结

A study of plasmatic concentrations of endothelin-1 (ET1), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in acute ischemic stroke.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female
  • age > 18
  • with an ischemic stroke

排除标准

  • cardiac failure
  • renal failure

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

终止
2 期
A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisPortal HypertensionAscitesCirrhosis
NCT03827200Noorik Biopharmaceuticals AG19
招募中
2 期
A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients elevated Albuminuria: a Randomized Double Blind Cross-Over Trialdiabetic kidney disease1001265310029149diabetic nephropathy
NL-OMON54022niversitair Medisch Centrum Groningen12
进行中(未招募)
1 期
A Study to Assess the Effects of the drugs Zibotentan and Dapagliflozin in Patients with Elevated Levels of Protein in UrinePatients with elevated AlbuminuriaMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10016807Term: Fluid retentionSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2021-001324-18-NLniversity Medical Center Groningen38
招募中
1 期
A Study to Assess the Effects of the drugs Zibotentan and Dapagliflozin in Patients with Type 2 Diabetes and Elevated Levels of Protein in UrinePatients with Type 2 Diabetes and elevated AlbuminuriaMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10016807Term: Fluid retentionSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2021-001324-18-DKniversity Medical Center Groningen36
已完成
不适用
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary ArteriesAtherosclerosis, Coronary
NCT00115583Brigham and Women's Hospital200